NCT06812585
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Nasser Institute for Research and Treatment Cairo, Cairo Governorate, Egypt
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
455 public trials
46 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
NCT06129019
- Conditions
- Anxiety Disorders, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +9 more
- Locations
-
- Firat University Elâzığ, Turkey (Türkiye)
NCT00676715
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
- Barrow Neurological Institute Phoenix, Arizona, United States
- East Bay Physicians Med Group;Sutter East Bay Med Foundation Berkeley, California, United States
- University of California San Francisco San Francisco, California, United States
NCT06127095
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Biogen Cambridge, Massachusetts, United States
NCT04997148
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- University Hospitals Coventry and Warwickshire- Neurology Coventry, United Kingdom
- NHS Lanarkshire Health Board- Department of Neurology Glasgow, United Kingdom
- Queen Elizabeth University Hospital Glasgow, United Kingdom
- University Hospitals of Leicester NHS Trust Leicester, United Kingdom
Completed
Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice
NCT06737419
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT03562975
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
- Locations
-
- Carol and Frank Morsani Center for Advanced Healthcare Tampa, Florida, United States
NCT02212886
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Barzilai Medical Center Ashkelon, Israel
- Rambam Medical Center Haifa, Israel
- TASMC Tel Aviv, Israel
NCT06705608
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Carcinoma, +26 more
- Locations
-
Not specified
Completed
Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab
NCT03157830
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- RWJBarnabas Health Livingston, New Jersey, United States
- Providence MS Center Portland, Oregon, United States
- Kadlec Neuroscience Center Richland, Washington, United States
- Multiple Sclerosis Center, Swedish Neuroscience Institute Seattle, Washington, United States